U.S. markets close in 2 hours 12 minutes
  • S&P 500

    3,846.65
    -23.64 (-0.61%)
     
  • Dow 30

    31,460.51
    +68.99 (+0.22%)
     
  • Nasdaq

    13,109.98
    -248.81 (-1.86%)
     
  • Russell 2000

    2,243.59
    +12.08 (+0.54%)
     
  • Crude Oil

    61.69
    +1.94 (+3.25%)
     
  • Gold

    1,716.70
    -16.90 (-0.97%)
     
  • Silver

    26.40
    -0.48 (-1.80%)
     
  • EUR/USD

    1.2077
    -0.0010 (-0.08%)
     
  • 10-Yr Bond

    1.4700
    +0.0550 (+3.89%)
     
  • GBP/USD

    1.3974
    +0.0018 (+0.13%)
     
  • USD/JPY

    106.9620
    +0.2520 (+0.24%)
     
  • BTC-USD

    51,388.82
    +3,618.27 (+7.57%)
     
  • CMC Crypto 200

    1,028.60
    +40.51 (+4.10%)
     
  • FTSE 100

    6,675.47
    +61.72 (+0.93%)
     
  • Nikkei 225

    29,559.10
    +150.93 (+0.51%)
     

Phathom Pharmaceuticals (PHAT) Surges: Stock Moves 6.9% Higher

  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.

Phathom Pharmaceuticals, Inc. PHAT was a big mover last session, as the company saw its shares rise nearly 7% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $38.20 to $45.46 in the past one-month time frame.

The company has seen one negative estimate revision in the past few weeks, while its Zacks Consensus Estimate for the current quarter has also moved lower over the past few weeks, suggesting there may be trouble down the road. So, make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Phathom Pharmaceuticals currently has a Zacks Rank #4 (Sell) while its Earnings ESP is 0.00%.

price chart for PHAT
price chart for PHAT


Investors interested in the Medical - Biomedical and Genetics industry may consider Alimera Sciences, Inc. ALIM, which has a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Alimera Sciences, Inc. (ALIM) : Free Stock Analysis Report
 
Phathom Pharmaceuticals, Inc. (PHAT) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research